FIELD: medicine.
SUBSTANCE: invention refers to biologically active peptides able to inhibit myosin light chain kinase and thereby regulate the variability of vascular endothelial permeability. What is offered is a cyclic nonapeptide of formula cyclo[-Arg-Lys-Lys-Tyr-Lys-Tyr-Arg-Arg-Lys-].
EFFECT: peptide can find application as a decongestant in various fields of medicine.
2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AMIDE OF NONAPEPTIDE PREVENTING INCREASE OF HYPERPERMEABILITY OF VESSEL ENDOTHELIUM | 2012 |
|
RU2493164C1 |
PROTEOLYTICALLY STABLE NONAPEPTIDE CAPABLE OF PREVENTING AN INCREASE IN HYPERPERMEABILITY OF VASCULAR ENDOTHELIUM | 2018 |
|
RU2682878C1 |
NONAPEPTIDE AMIDE, POSSESSING ABILITY TO PREVENT INCREASE OF VESSEL ENDOTHELIUM PERMEABILITY | 2009 |
|
RU2402565C1 |
METHOD OF PRODUCING NONAPEPTIDES | 2015 |
|
RU2592282C1 |
METHOD OF IMMUNE-ENZYME ASSAY FOR DETECTING β-ADRENORECEPTOR AUTOIMMUNE ANTIBODIES IN HUMAN BLOOD PLASMA AND SERUM | 2011 |
|
RU2452964C1 |
SYNTHETIC ANTIGEN ABILITY TO BIND β-ADRENORECEPTOR AUTOANTIBODIES | 2007 |
|
RU2356576C1 |
CRYSTALLOID CARDIOPLEGIC SOLUTIONS, CONTAINING DODECAPEPTIDES (VERSIONS) | 2013 |
|
RU2549470C1 |
DODECAPEPTIDES HAVING CARDIOPROTECTIVE PROPERTIES | 2010 |
|
RU2457216C1 |
PEPTIDE FOR INHIBITING FRACTALKINE-STIMULATED MIGRATION OF MONOCYTIC CELLS | 2011 |
|
RU2461565C1 |
METHOD OF OBTAINING DODECAPEPTIDE AND TRIPEPTIDE FOR ITS REALISATION | 2007 |
|
RU2340626C1 |
Authors
Dates
2012-02-27—Published
2010-10-13—Filed